These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1791223)

  • 1. Hypertriglyceridemia in patients with psoriasis treated with cyclosporine.
    Grossman RM; Delaney RJ; Brinton EA; Carter DM; Gottlieb AB
    J Am Acad Dermatol; 1991 Oct; 25(4):648-51. PubMed ID: 1791223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis.
    Brechtel B; Wellenreuther U; Toppe E; Czarnetzki BM
    J Am Acad Dermatol; 1994 Jun; 30(6):1023-4. PubMed ID: 8188867
    [No Abstract]   [Full Text] [Related]  

  • 6. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
    Ashley JM; Lowe NJ; Borok ME; Alfin-Slater RB
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):76-82. PubMed ID: 2969924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertriglyceridemia in patients with psoriasis treated with cyclosporine.
    Mrowietz U; Färber L; Bachmann H; Christophers E
    J Am Acad Dermatol; 1992 Sep; 27(3):491-2. PubMed ID: 1401300
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease.
    Stiller MJ; Pak GH; Kenny C; Jondreau L; Davis I; Wachsman S; Shupack JL
    J Am Acad Dermatol; 1992 Sep; 27(3):434-8. PubMed ID: 1401280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis.
    Shiohara T; Imanishi K; Sagawa Y; Nagashima M
    J Am Acad Dermatol; 1992 Oct; 27(4):568-74. PubMed ID: 1401309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports).
    Kokelj F; Plozzer C; Torsello P; Trevisan G
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate.
    Ellis CN; Kang S; Vinik AI; Grekin RC; Cunningham WJ; Voorhees JJ
    Arch Dermatol; 1987 Apr; 123(4):471-5. PubMed ID: 3548599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood lipids in patients after kidney transplantation].
    Grzeszczak W; Kokot F; Bar A; Darocha Z
    Pol Arch Med Wewn; 1992; 87(4-5):242-9. PubMed ID: 1523152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-alpha therapy in a patient with psoriatic arthritis and psoriasis vulgaris.
    Antoniou C; Dessinioti C; Katsambas A; Stratigos AJ
    Br J Dermatol; 2007 May; 156(5):1090-1. PubMed ID: 17408391
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man.
    Michaëlsson G; Bergqvist A; Vahlquist A; Vessby B
    Br J Dermatol; 1981 Aug; 105(2):201-5. PubMed ID: 7284249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etretinate therapy improves psoriasis but elevates serum lipids.
    Cowart VS
    JAMA; 1982 May; 247(19):2647-8. PubMed ID: 7077753
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of skeletal radiographic changes during short-term etretinate therapy for psoriasis.
    Gilbert M; Ellis CN; Voorhees JJ
    Dermatologica; 1986; 172(3):160-3. PubMed ID: 3699217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term increase in serum cholesterol levels in ulcerative colitis patients treated with cyclosporine: an underdiagnosed side effect frequently associated with other drug-related complications.
    Bálint A; Farkas K; Szűcs M; Szepes Z; Nagy F; Wittmann T; Molnár T
    Scand J Gastroenterol; 2014 Jan; 49(1):59-65. PubMed ID: 24138131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.